| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 05/30/2002 | WO2001079517A3 Control of fruit dehiscence in arabidopsis by indehiscent1 genes |
| 05/30/2002 | WO2001079498A3 16051a and 16051b, novel human pdz family members and uses thereof |
| 05/30/2002 | WO2001074858A3 Methods for altering t cell activation |
| 05/30/2002 | WO2001074854A3 32449, a putative human transporter and uses thereof |
| 05/30/2002 | WO2001073030A3 Compositions and methods of diagnosing, monitoring, staging, imaging and treating colon cancer |
| 05/30/2002 | WO2001068888A3 Production of chimeric capsid vectors |
| 05/30/2002 | WO2001068857A3 18615 and 48003, human ion channels and uses therefor |
| 05/30/2002 | WO2001068704A3 G-protein coupled receptors |
| 05/30/2002 | WO2001068702A3 Regulation of human g protein-coupled receptor |
| 05/30/2002 | WO2001066776A3 Novel l-form bacterial strains, method for producing same and the use thereof for producing gene products |
| 05/30/2002 | WO2001066760A3 Novel human kinase interacting protein and polynucleotides encoding the same |
| 05/30/2002 | WO2001066746A3 G-protein coupled receptor related polypeptides |
| 05/30/2002 | WO2001066689A3 Novel nucleic acids and polypeptides |
| 05/30/2002 | WO2001064877A3 Human schizophrenia gene |
| 05/30/2002 | WO2001053456A3 Methods and materials relating to prothrombinase-like polypeptides and polynucleotides |
| 05/30/2002 | WO2001049847A3 26904, 38911, and 39404, seven-transmembrane proteins/g-protein coupled receptors |
| 05/30/2002 | WO2001049840A3 Spf1-related transcription factors |
| 05/30/2002 | WO2001048179A9 Binding of polyamides to proteins having sh3 or ww domains |
| 05/30/2002 | WO2001046243A3 A new polypeptide-ring finger protein 8 and the polynucleotide encoding it |
| 05/30/2002 | WO2001045494A9 Pyrophosphatase stress-related proteins and methods of use in plants |
| 05/30/2002 | WO2001044816A3 Conformational and topological protein regulation |
| 05/30/2002 | WO2001042509A9 Use of multiple recombination sites with unique specificity in recombinational cloning |
| 05/30/2002 | WO2001041741A9 Hla class i a2 tumor associated antigen peptides and vaccine compositions |
| 05/30/2002 | WO2001040264A9 Peptide antigens |
| 05/30/2002 | WO2001039799A9 Passive desensitization |
| 05/30/2002 | WO2001039600A9 Use of hsp27 as an anti-inflammatory agent |
| 05/30/2002 | WO2001030998A9 Production of functional hybrid genes and proteins |
| 05/30/2002 | WO2001029063A8 Death domain-containing receptor polynucleotides, polypeptides, and antibodies |
| 05/30/2002 | WO2001021795A9 Fatty acid transport proteins |
| 05/30/2002 | WO2001020037A3 Peroxisome proliferator-activated receptor alpha and disorders of lipid metabolism |
| 05/30/2002 | WO2000078952A8 Human rna metabolism proteins (rmep) |
| 05/30/2002 | US20020066124 GTP binding stress-related proteins and methods of use in plants |
| 05/30/2002 | US20020066122 Hypersensitive response elicitor from Xanthomonas campestris |
| 05/30/2002 | US20020066120 Plant myb-related transcription factors |
| 05/30/2002 | US20020066117 Transgenic animal and methods |
| 05/30/2002 | US20020065407 Nucleotide sequences coding preferential polypeptide for use in the immunization of animal against viral diseases |
| 05/30/2002 | US20020065405 Nucleotide sequences coding receptor protein for use in the treatment of defects in the detection of odor |
| 05/30/2002 | US20020065404 Cytidine monophosphate-sialic acid transporter, and hexosaminidase polynucleotides and polypeptides, and uses based thereon. |
| 05/30/2002 | US20020065398 Humanized and chimeric monoclonal antibodies that recognize epidermal growth factor receptor (egf-r); diagnostic and therapeutic use |
| 05/30/2002 | US20020065396 Compositions and methods of diagnosing, monitoring, staging, imaging and treating colon cancer |
| 05/30/2002 | US20020065395 Polypeptide for use as diagnostic tool in screening bactericides |
| 05/30/2002 | US20020065394 Nucleotide sequences for use in human diagnostics and therapeutics |
| 05/30/2002 | US20020065392 Methods for production of protein |
| 05/30/2002 | US20020065264 Heterocylic leaving group containing -o-Het, or -s-Het, wherein Heterocyclic rings selected from pyridine, pyrole, furan, pyrimidine or proline derivatives |
| 05/30/2002 | US20020065241 A recombinant polynucleotide of first polynucleotides coding an antigenic peptide and are operatively linked to each other to enhance translation of the polynucleotides to the peptides and binding to MHC; cancer vaccine |
| 05/30/2002 | US20020065240 Gene therapy for stimulation of angiogenesis |
| 05/30/2002 | US20020065238 EPO primary response gene, EPRG3pt |
| 05/30/2002 | US20020065237 SBHWSB1 polypeptides/polynucleotides produced by recombinant techniques; gene therapy; diagnostic tests; agonists; antagonists; "positional cloning"; sequence of Serine(S), Aspargine/Asparic Acid(W), Histidine (H) and Tryptophan (T) |
| 05/30/2002 | US20020065227 Charged compounds comprising a nucleic acid binding moiety and uses therefor |
| 05/30/2002 | US20020065225 Methods of determining altered NDPK functions and the diagnosis of cystic fibrosis |
| 05/30/2002 | US20020065224 Caveolin-1 polypeptide as an antiproliferative, -carcinogenic and -tumor agents; especially preferred to treat colon and stomach cancer; non-steroid dependent carcinoma; conjugated to a carrier, e.g. an antibody |
| 05/30/2002 | US20020065223 Isolated nucleic acid molecules encoding C/SKARP)-1 (Cardiac/Skeletal Muscle-Restricted Ankyrin-Repeat Containing Protein); antisense nucleic acid molecules, recombinant expression vectors; cardiotonic agents; muscles disorders |
| 05/30/2002 | US20020065220 For use in diagnosis and therapy of disorders treating disorders related to these novel human immunoglobulin-like (Ig- like) proteins |
| 05/30/2002 | US20020065218 VEGF-D/VEGF-C/VEGF peptidomimetic inhibitor |
| 05/30/2002 | US20020065216 Novel method of diagnosing and treating gliomas |
| 05/30/2002 | US20020065215 Isolated P2Y-like receptor polypeptide, polynucleotides encoding the same and methods of screening compounds as modulators of P2Y receptors or their expression; purinergic receptors |
| 05/30/2002 | US20020065213 Increasing the duration of expression of a delivered gene in target cells by delivering a gene encoding a cellular retention activity and nuclear binding sequence to target cells before or during gene of interest delivery |
| 05/30/2002 | US20020065211 Increasing function of organs having reduced red blood cell flow |
| 05/30/2002 | US20020065210 DcR3 polypeptide, a TNFR homolog |
| 05/30/2002 | US20020065046 Apparatuses, methods, and computer programs for showing information on a vehicle having multiple displays |
| 05/30/2002 | US20020064876 Genetically engineering cells of skin; obtain cells, transform with expression vector, monitor cells for preferential phenotypes |
| 05/30/2002 | US20020064872 Polypeptide for use in the detection and prevention of tumors; antitumor agents; anticarcinogenic agents |
| 05/30/2002 | US20020064871 Endogenous ketogulonigenium plasmid |
| 05/30/2002 | US20020064869 Polypeptide for use in treatment of lymphadenopathy, autoimmune disease and graft versus host disease; antitumor agents |
| 05/30/2002 | US20020064865 Crystal protein for use in bological pest control |
| 05/30/2002 | US20020064863 yacM1 |
| 05/30/2002 | US20020064862 Preventing viral replication in cells; obtain cells, incubate with viricide, monitor cells for reduced viral activity |
| 05/30/2002 | US20020064860 Isolating viral particle from mixed sample; obtain sample, expose to chromatographic column, elute, recover viral particles |
| 05/30/2002 | US20020064855 Nucleotide sequences for use in the treatment of leukemia |
| 05/30/2002 | US20020064848 Novel histidinol dehydrogenase |
| 05/30/2002 | US20020064846 Protein for use treatment of diabetes |
| 05/30/2002 | US20020064842 Renilla reniformis green fluorescent protein and mutants thereof |
| 05/30/2002 | US20020064839 Nucleotide sequences which code for the oxyR gene |
| 05/30/2002 | US20020064838 Means and methods for monitoring protease inhibitor antiretroviral therapy and guiding therapeutic decisions in the treatment of HIV/AIDS |
| 05/30/2002 | US20020064835 Generating muscle protein; obtain sample, incubate under reducing environment, recover muscle protein |
| 05/30/2002 | US20020064833 Nucleotide sequences for use in the treatment of drug abuse and drug dependence |
| 05/30/2002 | US20020064832 Method of treating fibroproliferative disorders |
| 05/30/2002 | US20020064831 Nucleotide sequences coding polypeptides associated capillary morphogenesis; for use in controlling neovascularization; antitumor agents |
| 05/30/2002 | US20020064830 Nucleotide sequences for use as diagnostic tools |
| 05/30/2002 | US20020064829 Human tumor necrosis factor delta and epsilon |
| 05/30/2002 | US20020064828 Method of controlling the binding of calmyrin to presenilin |
| 05/30/2002 | US20020064827 yacM2 |
| 05/30/2002 | US20020064826 Cytokine receptor-like polynucleotides, polypeptides, and antibodies |
| 05/30/2002 | US20020064825 Nucleotide sequences coding preferential polypeptide; for use in dietetics, osteoporosis, diabetes, nervous system, skin, vision, psychological, urogenital, cardiovascular, sleep, respiratory, gastrointestinal and sex disorders |
| 05/30/2002 | US20020064824 Generating preferential binding protein; obtain nucleotide sequences, replace preferential nucleotides, translate nucleotide sequences, recover preferential protein |
| 05/30/2002 | US20020064823 Nucleotide sequences which code binding protein for use in human therapeutics and gene therapy |
| 05/30/2002 | US20020064822 Isolated human G-protein coupled receptors, nucleic acid molecules encoding human GPCR proteins, and uses thereof |
| 05/30/2002 | US20020064821 Isolated human ion channel proteins, nucleic acid molecules encoding human ion channel proteins, and uses thereof |
| 05/30/2002 | US20020064820 Apo-A-I regulation of T-cell signaling |
| 05/30/2002 | US20020064819 Polypeptide for use in the treatament and prevention of nervous system disorders |
| 05/30/2002 | US20020064818 Nucleotide sequences coding preferential polypeptide; for use in diagnosis and treatment of cancer, nervous system, inflammatory and immunological disorders |
| 05/30/2002 | US20020064817 Nucleotide sequences coding membrane protein for use in detection of odors; developing fragrances; detecting appetite suppressant; controlling rodents; preventing fertility |
| 05/30/2002 | US20020064816 Nuclelotide sequences coding polysaccharide metabolism protein for use in generating transgenic plants |
| 05/30/2002 | US20020064815 Ovarian tumor antigen and methods of use therefor |
| 05/30/2002 | US20020064814 Dog orexin 1 receptor |
| 05/30/2002 | US20020064813 Nucleotide sequences for use in the treatment of infections, pain; cancers; diabetes, eating, psychological, urogenital and neurological disorders; hypotension; hypertension; osteoporosis; angina pectoris; stroke; ulcers; allergies |
| 05/30/2002 | US20020064812 Plasmid for use in the treatment of blood disorders |
| 05/30/2002 | US20020064811 Dna encoding the human synapsin iii gene and uses thereof |
| 05/30/2002 | US20020064802 Associating protein with chromosomes; monitor chromosome, detect target association position, transform cell, detect proteins association with chromosome |
| 05/30/2002 | US20020064801 Immunoassay for detecting exposure to Leishmania parasites; obtain sample, incubate with soluble antigen, measure amount of antibody bound to soluble antigen |